Solventum To Acquire Privately-held Acera Surgical For Up To $850 Mln

Solventum Announces Agreement to Acquire Acera Surgical

Solventum (SOLV) Is Up 5.8% After Q3 Profit Surges and Full-Year Outlook Raised—Has the Bull Case Changed?

Solventum Reports Third Quarter 2025 Financial Results

Solventum’s (NYSE:SOLV) Q3: Beats On Revenue

Solventum to Participate in the 2025 Stifel Healthcare Conference

Why Analysts See the Story Changing for Solventum After Key Portfolio Moves and Growth Updates

Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Should Solventum's (SOLV) New CCO Signal a Turning Point for Its Commercial Strategy?

Should Investors Revisit Solventum After 8.4% Share Price Gain in 2025?

Solventum hires Heather Knight from Baxter to fill new C-suite post

Solventum Appoints Heather Knight as Chief Commercial Officer

Solventum hires Baxter EVP and COO Heather Knight for new C-suite role

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

Solventum (SOLV): Is There Value After Recent Momentum Shift?

Why Analysts Are Rethinking Solventum’s Outlook After Portfolio Sale and Strategy Shift

Is Solventum Stock Underperforming the S&P 500?

US companies are using AI to help offset increased tariff costs

Is Solventum Corporation (SOLV) Stock Outpacing Its Medical Peers This Year?

Solventum price target raised by $3 at Wells Fargo, here's why

Solventum Completes $2 Billion Tender Offers for Outstanding Notes

Solventum in $2 Billion Tender Offers | News

Solventum initiated with neutral view at Jefferies, here's why

Thermo Fisher Expands Reach with Solventum Buy

Thermo Fisher closes $4B Solventum filtration deal, adds Sanofi’s New Jersey fill-finish site

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

Solventum Prices Upsized Tender Offers for Senior Notes

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

Solventum Announces Early Tender Results and Upsizing of Its Note Tender Offers

Solventum announces pricing of its upsized $2 bln note tender offers

Vesey Street Capital Partners Adds Three Seasoned Healthcare Industry Leaders to Strategic Advisory Board

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

Solventum Reports Early Results of Tender Offers

Solventum completes $4.1B sale of Purification & Filtration business to Thermo Fisher

Double play: Thermo acquires Solventum filtration business and Sanofi facility

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business

Why Thermo Fisher Scientific Stock Tumbled Today

Exergen Appoints Paula McGrane as New European Commercial Director to Support Growth and Adoption

Thermo Fisher Scientific Acquires Solventum’s Purification and Filtration Business For $4 Billion

Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific

Solventum to Participate in Upcoming Investor Conferences

Healthcare Leader Solventum Set for Major September Investor Conferences at Wells Fargo and Morgan Stanley

Wound Dressings Market worth US$15.87 billion by 2030 with 6.5% CAGR | MarketsandMarkets™

LATAM Advanced Wound Care Company Evaluation Report 2025 | Solventum, Smith+Nephew, and Cardinal Health Lead with Advanced Medtech, Surgical Solutions, and Supply Chain Leadership

Traditional Wound Care Industry Company Evaluation Report 2025 | Solventum, Cardinal Health, and Smith+Nephew Lead with Innovations, Supply Chain Leadership, and Advanced Medtech Solutions

Solventum Announces $1.75 Billion Note Tender Offers

Thermo Fisher opens automated lab tools plant in North Carolina

Do Wall Street Analysts Like Solventum Stock?

Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings

Australia's Top Healthcare IT Vendors Named by Black Book Research in 2025 Annual User Rankings

Investors Can Find Comfort In Solventum's (NYSE:SOLV) Earnings Quality

Solventum Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

3M Prices $648 Million Secondary Offering of Solventum Shares

Solventum 8.8M share Spot Secondary priced at $73.65

3M to sell Solventum shares for $648 million in secondary offering

Solventum Announces Pricing of Secondary Offering of Common Stock

Solventum Announces Launch of Secondary Offering of Common Stock

5 Insightful Analyst Questions From Solventum’s Q2 Earnings Call

Single-use Filtration Assemblies Market Size Projected to Surpass USD 17.91 Billion by 2032 To Forecast 2025-2032

Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings

Wound Care Market worth US$30.48 billion by 2030 with 6.5% CAGR | MarketsandMarkets™

Wound Care Market worth US$30.48 billion by 2030 with 6.5% CAGR | MarketsandMarkets™

Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve

Solventum Exceeds 2Q25 Expectations with $2.16B Revenue, Reduces Tariff Impact

Solventum Reports Second Quarter 2025 Financial Results

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Solventum beats The Street in Q2, raises full-year guidance

Solventum raises FY25 adjusted EPS view to $5.80-$5.95 from $5.45-$5.65

Solventum reports Q2 adjusted EPS $1.69, consensus $1.45

Solventum Reports Second Quarter 2025 Financial Results

Solventum ups financial guidance as tariff risks fade

Transcript : Solventum Corporation, Q2 2025 Earnings Call, Aug 07, 2025

Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?

Industry Insider: After 3M Separation, Solventum Targets Digital Integration in Ortho

Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™.

The highest-paid medtech CEOs of 2024

What to Expect From Solventum's Q2 2025 Earnings Report

Transcript : Thermo Fisher Scientific Inc., Q2 2025 Earnings Call, Jul 23, 2025

$717.3 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern Diagnostics | MarketsandMarkets™

As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE)

Advanced Wound Care Market worth $19.32 billion by 2030 with 7.6% CAGR | MarketsandMarkets™

Advanced Wound Care Market worth $19.32 billion by 2030 with 7.6% CAGR | MarketsandMarkets™

Where CEOs live becomes source of debate as companies tighten in-office policies

Minnesota’s highest paid CEOs made 7% more last year, with No. 1 making $59.4M

Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research

Is the Options Market Predicting a Spike in Solventum Stock?

$0.71 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern Diagnostics | MarketsandMarkets™

$0.71 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern Diagnostics | MarketsandMarkets™

Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business

Solventum Named a Best Company to Work for by U.S. News & World Report

Medical Tapes and Bandages Market Size worth $9.86 billion, Globally, by 2030 - Exclusive Study by The Research Insights

Black Book Research Highlights 15 Top-Rated Healthcare IT Vendors Exhibiting at HIMSS 25 Europe in Paris

Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization